[:no]Midtveisevalueringer uke 49[:]

[:no]Synnøve Yndestad
Tid: 2. desember kl. 8:00
Sted: Laboratoriebygget 8. etg, møterom 8.1
For mer informasjon

Agnete Lund
Tid: 3. desember kl. 8:00
Sted: Laboratoriebygget 7. etg, møterom 7.1 /7.2
For mer informasjon

Christel Gill Haanshuus
Tid: 3. desember kl. 11:00
Sted: Laboratoriebygget 7. etg, møterom 7.1 /7.2
For mer informasjon

Rune Skjåstad
Tid: 3. desember kl. 14:45
Sted: Laboratoriebygget 7. etg, møterom 7.1 /7.2
For mer informasjon[:en]Synnøve Yndestad
Time: December 2 at  8:00
Place: Laboratoriebygget 7. etg, room 7.1/7.2
For mer informasjon

Agnete Lund
Time: December 3 at 8:00
Place: Laboratoriebygget 7. etg, room 7.1 /7.2
For mer informasjon

Christel Gill Haanshuus
Time: December 3. at 11:00
Place: Laboratoriebygget 7. etg, room 7.1 /7.2
For mer informasjon

Rune Skjåstad
Time: December 3. at 14:45
Place: Laboratoriebygget 7. etg, room 7.1 /7.2
For mer informasjon[:]

[:no]Nye publikasjoner[:en]New Publications[:]

[:no]Basert på siste ukes søk på “Department of Clinical Science AND Bergen”. Hvis du har publikasjoner som ikke favnes av dette søket, send referansen til elin.opheim@uib.no.

Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.
Berg JA, Schjøtt J, Fossan KO, Riedel B.
Subst Abuse Rehabil. 2015 Oct 28;6:131-139

The Expression of BAFF Is Controlled by IRF Transcription Factors.
Sjöstrand M, Johansson A, Aqrawi L, Olsson T, Wahren-Herlenius M, Espinosa A.
J Immunol. 2015 Nov 20.

Parental anxiety related to referral of childhood heart murmur; an observational/interventional study.
Bårdsen T, Sørbye MH, Trønnes H, Greve G, Berg A.
BMC Pediatr. 2015 Nov 21;15(1):193.

EHRA research network surveys: 6 years of EP wires activity.
Bongiorni MG, Chen J, Dagres N, Estner H, Hernandez-Madrid A, Hocini M, Larsen TB, Pison L, Potpara T, Proclemer A, Sciaraffia E, Todd D, Blomstrom-Lundqvist C.
Europace. 2015 Nov;17(11):1733-8.

Perceived food intolerance and irritable bowel syndrome in a population 3 years after a giardiasis-outbreak: a historical cohort study.
Litleskare S, Wensaas KA, Eide GE, Hanevik K, Kahrs GE, Langeland N, Rortveit G.
BMC Gastroenterol. 2015 Nov 19;15(1):164.

Unilateral renal ischemia in rats induces a rapid secretion of inflammatory markers to renal lymph and increased peritubular capillary permeability.
Bivol LM, Iversen BM, Hultström M, Wallace PW, Reed RK, Wiig H, Tenstad O.
J Physiol. 2015 Nov 20.

CYP19A1 fine-mapping and Mendelian randomisation: estradiol is causal for endometrial cancer.
Thompson DJ, O’Mara TA, Glubb DM, Painter JN, Cheng T, Folkerd E, Doody D, Dennis J, Webb PM, Gorman M, Martin L, Hodgson S, Michailidou K, Tyrer JP, Maranian MJ, Hall P, Czene K, Darabi H, Li J, Fasching PA, Hein A, Beckmann MW, Ekici AB, Dörk T, Hillemanns P, Dürst M, Runnebaum I, Zhao H, Depreeuw J, Schrauwen S, Amant F, Goode EL, Fridley BL, Dowdy SC, Winham SJ, Salvesen HB, Trovik J, Njolstad TS, Werner HM, Ashton K, Proietto T, Otton G, Carvajal-Carmona L, Tham E, Liu T, Mints M, Scott RJ, McEvoy M, Attia J, Holliday EG, Montgomery GW, Martin NG, Nyholt DR, Henders AK, Hopper JL, Traficante N, Ruebner M, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Lambrechts D, Chang-Claude J, Couch F, Giles G, Kristensen VN, Cox A, Bolla MK, Wang Q, Bojesen SE, Shah M, Luben R, Khaw KT, Pharoah PD, Dunning AM, Tomlinson I, Dowsett M, Easton DF, Spurdle AB.
Endocr Relat Cancer. 2015 Nov 16.

 [:en]Based on last week’s search for “Department of Clinical Science AND Bergen”. If you have publications which are not covered by this search, send the reference to elin.opheim@uib.no.

Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.
Berg JA, Schjøtt J, Fossan KO, Riedel B.
Subst Abuse Rehabil. 2015 Oct 28;6:131-139

The Expression of BAFF Is Controlled by IRF Transcription Factors.
Sjöstrand M, Johansson A, Aqrawi L, Olsson T, Wahren-Herlenius M, Espinosa A.
J Immunol. 2015 Nov 20.

Parental anxiety related to referral of childhood heart murmur; an observational/interventional study.
Bårdsen T, Sørbye MH, Trønnes H, Greve G, Berg A.
BMC Pediatr. 2015 Nov 21;15(1):193.

EHRA research network surveys: 6 years of EP wires activity.
Bongiorni MG, Chen J, Dagres N, Estner H, Hernandez-Madrid A, Hocini M, Larsen TB, Pison L, Potpara T, Proclemer A, Sciaraffia E, Todd D, Blomstrom-Lundqvist C.
Europace. 2015 Nov;17(11):1733-8.

Perceived food intolerance and irritable bowel syndrome in a population 3 years after a giardiasis-outbreak: a historical cohort study.
Litleskare S, Wensaas KA, Eide GE, Hanevik K, Kahrs GE, Langeland N, Rortveit G.
BMC Gastroenterol. 2015 Nov 19;15(1):164.

Unilateral renal ischemia in rats induces a rapid secretion of inflammatory markers to renal lymph and increased peritubular capillary permeability.
Bivol LM, Iversen BM, Hultström M, Wallace PW, Reed RK, Wiig H, Tenstad O.
J Physiol. 2015 Nov 20.

CYP19A1 fine-mapping and Mendelian randomisation: estradiol is causal for endometrial cancer.
Thompson DJ, O’Mara TA, Glubb DM, Painter JN, Cheng T, Folkerd E, Doody D, Dennis J, Webb PM, Gorman M, Martin L, Hodgson S, Michailidou K, Tyrer JP, Maranian MJ, Hall P, Czene K, Darabi H, Li J, Fasching PA, Hein A, Beckmann MW, Ekici AB, Dörk T, Hillemanns P, Dürst M, Runnebaum I, Zhao H, Depreeuw J, Schrauwen S, Amant F, Goode EL, Fridley BL, Dowdy SC, Winham SJ, Salvesen HB, Trovik J, Njolstad TS, Werner HM, Ashton K, Proietto T, Otton G, Carvajal-Carmona L, Tham E, Liu T, Mints M, Scott RJ, McEvoy M, Attia J, Holliday EG, Montgomery GW, Martin NG, Nyholt DR, Henders AK, Hopper JL, Traficante N, Ruebner M, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Lambrechts D, Chang-Claude J, Couch F, Giles G, Kristensen VN, Cox A, Bolla MK, Wang Q, Bojesen SE, Shah M, Luben R, Khaw KT, Pharoah PD, Dunning AM, Tomlinson I, Dowsett M, Easton DF, Spurdle AB.
Endocr Relat Cancer. 2015 Nov 16.

 [:]

[:no]Trenger vitenskapelig personale å bry seg om karriere ?[:en]Does scientific staff need to care about careers?[:]

[:no]Roland JonssonKarrierebegrepet kan for mange oppfattes som et verdiladet begrep, men for dem som arbeider innen akademia er dette en realitet.  Per i dag stilles store krav om å rekruttere de beste talentene og gi dem så god oppfølging at de blir værende ved institusjonen dvs. i vårt tilfelle Klinisk institutt 2. Dette gjelder for at norske institusjoner skal kunne hevde seg sterkere i den internasjonale konkurransen om talenter og forskningsmidler. Da må også ledere på alle nivåer prioritere god rekrutterings- og karrierepolitikk. Nylig leverte en arbeidsgruppe nedsatt av UHR et inspirasjonsdokument med forslag om et helhetlig rammeverk for karrierepolitikken ved norske UH-institusjoner. Rapporten finner du her: http://www.uhr.no/documents/230615KarrieredokumentetUHR.pdf

I inspirasjonsnotatet Bedre Karrierepolitikk for vitenskapelig personale i UH-sektoren (UHR juni 2015), som rapporten er blitt kalt, foreslår arbeidsgruppen å systematisere sin karriere- og HR-politikk inn mot fire faser i en vitenskapelig karriere:

  • De som er i organisert doktorgradsutdanning (ph.d.)
  • Ansatte på kvalifiseringsnivå (postdoc, forskere etc.)
  • Fast ansatte i kombinerte stillinger (1. amanuensis, professor, etc.)
  • Internasjonalt ledende professorer

Karrierepolitikk handler naturligvis om hele karriereløpet, fra ph.d. til internasjonalt ledende professorer. Dette bør vi ta fatt på og arbeide videre med. Det beste tidspunktet å ta dette opp er ved medarbeidersamtalen.

Roland[:en]Roland JonssonThe term career is by many perceived as a value-laden concept, but for those who work in academia this is a reality. At present there are great demands to recruit the best talents and follow them up so well that they remain at the institution, in our case Department of Clinical Science. This applies to ensure that Norwegian institutions will be able to assert themselves in the international competition for talents and research funding. To make this work, leaders at all levels need to prioritize good recruitment and career policy. Recently a working group appointed by UHR delivered an inspirational document with proposals for a coherent framework for career policy at Norwegian higher education institutions. The report can be found here (in norwegian): http://www.uhr.no/documents/230615KarrieredokumentetUHR.pdf

In the inspiration note Better Career Policies for academic staff in the higher education sector (UHR June 2015), that the report has been called, the working group proposes to systematise career and HR policy into four phases in a scientific career:

  • Phase 1. Those who are in a doctoral program (PhD)
  • Phase 2. Employees in qualification level (postdocs, researchers etc.)
  • Phase 3. Permanent employees in combined positions (Associate professor, professor, etc.)
  • Phase 4. Internationally leading professors

Career Politics is of course about the whole career path, from PhD to internationally leading professors. We should embark on and continue to work with this. The best time to bring this up is in the appraisal interview.

Roland[:]

[:no]Nytt om navn[:en]New Names[:]

[:no]Vi presenZuzana Sichmanovaterer Zuzana Sichmanova, PhD-student ved Mohn Kreftforskningslaboratorium, klinisk institutt 2. Zuzana begynte med doktorgradsarbeidet sitt i oktober 2015 under veiledning av Stian Knappskog.
Hvis noen ønsker å si hei, du kan finne henne i etasje 1M i laboratoriebygget.[:en]Zuzana SichmanovaWe present Zuzana Sichmanova, PhD student at Mohn Cancer Research Laboratory, Department of Clinical Science.
Zuzana started with her PhD work in October 2015 under the supervision of Stian Knappskog. If anyone
wants to say hello, you can find her in the 1M floor in the lab building.[:]